Carl Grunfeld

Q: What Schools Are Affiliated With Carl Grunfeld

Carl Grunfeld is affiliated with the following schools: Medical University of South Carolina, University of California, San Francisco

Carl Grunfeld's AcademicInfluence.com Rankings

Carl Grunfeld

Philosophy

#4381

World Rank

#6870

Historical Rank

Logic

#1847

World Rank

#2700

Historical Rank

philosophy Degrees

Carl Grunfeld

Biology

#5699

World Rank

#8241

Historical Rank

Endocrinology

#48

World Rank

#56

Historical Rank

Molecular Biology

#533

World Rank

#546

Historical Rank

Biochemistry

#699

World Rank

#799

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Carl Grunfeld's Degrees

Masters Medicine University of California, San Francisco
PhD Biochemistry University of California, San Francisco

Why Is Carl Grunfeld Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carl Grunfeld's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes (1985) (1886)
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. (2004) (1196)
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. (1996) (924)
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1992) (882)
Leptin regulation of the immune response and the immunodeficiency of malnutrition 1 (2001) (510)
Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability (1996) (463)
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. (1992) (441)
Hypertriglyceridemia in the acquired immunodeficiency syndrome. (1989) (438)
Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV‐1 Infection: Recommendations of an International AIDS Society‐USA Panel (2002) (419)
Infection and inflammation-induced proatherogenic changes of lipoproteins. (2000) (408)
Association of tenofovir exposure with kidney disease risk in HIV infection (2012) (403)
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. (1992) (399)
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. (1987) (397)
Role of Cytokines in Inducing Hyperlipidemia (1992) (392)
Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol (2002) (380)
Fat distribution and metabolic changes in patients with HIV infection. (1999) (379)
Metabolic effects of indinavir in healthy HIV-seronegative men (2001) (364)
Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. (1992) (350)
Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. (2000) (349)
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. (1992) (344)
Introduction to Lipids and Lipoproteins (2015) (343)
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study (2009) (335)
Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. (2000) (330)
Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. (1990) (322)
Interleukin-6 stimulates hepatic triglyceride secretion in rats. (1995) (306)
IL-1β mediates leptin induction during inflammation. (1998) (287)
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naïve cohort (2005) (286)
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study (2002) (283)
Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. (1996) (279)
Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort (2010) (278)
Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1992) (272)
Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting (1996) (270)
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. (1986) (269)
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. (1998) (261)
State of the Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS Executive Summary (2008) (251)
Waist Circumference Correlates with Metabolic Syndrome Indicators Better Than Percentage Fat (2006) (251)
Fat Distribution in Men With HIV Infection (2005) (246)
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver* (2000) (245)
Leptin deficiency enhances sensitivity to endotoxin-induced lethality. (1999) (245)
Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome (1991) (240)
Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. (1993) (240)
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection (2000) (235)
Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by (2000) (231)
Infection and inflammation induce LDL oxidation in vivo. (2000) (228)
Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. (1996) (226)
Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. (1993) (223)
The metabolic effects of lopinavir/ritonavir in HIV-negative men (2004) (221)
Role for circulating lipoproteins in protection from endotoxin toxicity (1995) (219)
Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. (1993) (218)
Multiple cytokines stimulate hepatic lipid synthesis in vivo. (1989) (210)
The metabolic effects of tumor necrosis factor and other cytokines (1991) (208)
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. (1993) (207)
Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. (1992) (206)
Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. (1993) (198)
Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. (2002) (197)
Mechanisms of triglyceride accumulation in activated macrophages (2012) (189)
Inflammation stimulates the expression of PCSK9. (2008) (185)
Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. (1989) (184)
Reduced leptin levels in starvation increase susceptibility to endotoxic shock. (2000) (181)
Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. (1993) (179)
Aesthesiometry: quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. (1988) (168)
Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. (1993) (166)
Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. (1998) (164)
Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons (2010) (164)
Repression of Farnesoid X Receptor during the Acute Phase Response* (2003) (156)
Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. (1981) (155)
Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. (2003) (154)
Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists (2005) (152)
Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. (2004) (151)
Microalbuminuria in HIV infection (2007) (151)
Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. (2007) (150)
IL-1 beta mediates leptin induction during inflammation. (1998) (148)
Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. (1994) (148)
Insulin receptors, receptor antibodies, and the mechanism of insulin action. (1981) (148)
Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. (1998) (145)
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. (2000) (144)
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. (2007) (140)
Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. (1983) (139)
Sonography of the sole of the foot. Evidence for loss of foot pad thickness in diabetes and its relationship to ulceration of the foot. (1986) (139)
Lipoproteins inhibit macrophage activation by lipoteichoic acid. (1999) (138)
Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. (2012) (135)
LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. (1997) (133)
The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. (2001) (127)
Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. (1989) (127)
Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels: The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study (2008) (125)
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. (1989) (124)
Association of Upper Trunk and Visceral Adipose Tissue Volume With Insulin Resistance in Control and HIV-Infected Subjects in the FRAM Study (2007) (123)
The Effect of Inflammation and Infection on Lipids and Lipoproteins (2015) (122)
Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. (1997) (120)
Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. (1991) (118)
Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. (1996) (115)
Incidence of Lipoatrophy and Lipohypertrophy in the Women's Interagency HIV Study (2003) (115)
Effects of a mindfulness‐based weight loss intervention in adults with obesity: A randomized clinical trial (2016) (115)
Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine (2005) (114)
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. (2009) (114)
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. (1989) (113)
Tumor Necrosis Factor, Interleukin, and Interferon Induced Changes in Lipid Metabolism as Part of Host Defense (1992) (113)
Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. (1994) (112)
The acute phase response stimulates the expression of angiopoietin like protein 4. (2010) (112)
FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. (2012) (111)
Body Mass Index as a Phenotypic Expression of Adiposity: Quantitative Contribution of Muscularity in a Population-Based Sample (2009) (111)
Triglyceride-rich lipoproteins prevent septic death in rats (1995) (110)
LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney* (2008) (109)
The acute effects of human growth hormone administration on thyroid function in normal men. (1988) (108)
Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection (2011) (107)
Subchronic sleep restriction causes tissue-specific insulin resistance. (2015) (107)
Visceral adipose tissue: relationships between single slice areas at different locations and obesity-related health risks (2007) (106)
Regulation of insulin receptors and insulin responsiveness in 3T3-L1 fatty fibroblasts. (1979) (105)
Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. (1990) (104)
Regulation of lipid metabolism by cytokines during host defense. (1996) (103)
Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients (2004) (103)
Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. (1995) (102)
Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. (1990) (101)
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. (2010) (101)
The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. (2006) (100)
Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy (2007) (99)
Insulin‐like Growth Factor 1 and Functional Status in Healthy Older Men (1995) (99)
The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men (2008) (99)
Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. (2012) (99)
Glucocorticoid-induced insulin resistance in vitro: evidence for both receptor and postreceptor defects. (1981) (98)
Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. (1999) (98)
Discordant regulation of proteins of cholesterol metabolism during the acute phase response. (1995) (95)
Illicit drug use and HIV treatment outcomes in a US cohort (2008) (94)
Dyslipidemia and its Treatment in HIV Infection. (2010) (93)
Effect of inflammation on HDL structure and function (2016) (93)
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. (2002) (92)
Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. (1988) (91)
Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. (2004) (91)
Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. (1988) (91)
Diabetic foot ulcers: etiology, treatment, and prevention. (1992) (91)
Serum leptin levels in the acquired immunodeficiency syndrome. (1996) (90)
Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era (2010) (89)
Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. (1991) (88)
Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice. (2000) (88)
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection (2004) (87)
Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. (2002) (87)
Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin (1997) (86)
Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. (2013) (86)
Sonography of the hand and foot in foreign body detection. (1987) (85)
Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. (1994) (85)
Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance. (1979) (85)
Receptor-mediated endocytosis of insulin: role of microvilli, coated pits, and coated vesicles. (1982) (85)
Induction of UCP2 gene expression by LPS: a potential mechanism for increased thermogenesis during infection. (1998) (84)
Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis (2009) (83)
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care (2011) (83)
Leptin deficiency enhances sensitivity to endotoxin-induced lethality. (1999) (82)
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. (1996) (82)
Chylomicrons enhance endotoxin excretion in bile (1993) (81)
Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. (2005) (81)
The protective effect of serum lipoproteins against bacterial lipopolysaccharide. (1993) (80)
Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. (2004) (78)
Effects of endotoxin on lipid metabolism. (1995) (77)
Association of antiretroviral therapy with fibrinogen levels in HIV-infection (2008) (75)
Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy (2010) (75)
The Relationship between Body Mass Index and Mental Health Among Iraq and Afghanistan Veterans (2013) (75)
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. (1989) (73)
HIV therapy, metabolic syndrome, and cardiovascular risk (2008) (73)
The role of HDL in innate immunity1 (2011) (73)
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. (2008) (72)
Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome: 12-Week Induction and 24-Week Maintenance Therapy (2007) (72)
Heel pad thickness: determination by high‐resolution ultrasonography. (1985) (72)
Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6. (1990) (72)
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. (1990) (71)
In Vivo and in Vitro Regulation of Sterol 27-Hydroxylase in the Liver during the Acute Phase Response (2001) (71)
Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans (2015) (71)
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study (2011) (71)
Infection and inflammation decrease apolipoprotein M expression. (2008) (70)
Use of Liquid Crystal Thermography in the Evaluation of the Diabetic Foot (1986) (70)
The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs. (1992) (69)
HIV viremia and changes in kidney function (2009) (68)
Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factor. (1993) (68)
Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. (1998) (68)
Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis. (1992) (66)
Insulin-receptor antibodies mimic a late insulin effect (1979) (64)
Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. (1990) (64)
Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. (2001) (63)
Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. (2001) (63)
Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. (2003) (63)
Barrier function coordinately regulates epidermal IL‐1 and IL‐1 receptor antagonist mRNA levels (1994) (62)
The acute phase response inhibits reverse cholesterol transport1 (2010) (62)
Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. (1999) (62)
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. (1994) (61)
Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis (2012) (60)
Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. (1995) (60)
Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. (1997) (60)
Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages (2014) (60)
In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. (1999) (59)
Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo. (1992) (59)
Relationship of fat distribution with adipokines in human immunodeficiency virus infection. (2008) (58)
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers (2007) (58)
Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults (2011) (58)
Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. (2006) (57)
Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men: A Randomized, Double-Blind, Placebo-Controlled Study (2006) (57)
In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. (1998) (57)
Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. (1995) (56)
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists. (2010) (55)
Beneficial effects of cytokine induced hyperlipidemia. (1998) (55)
LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. (2008) (55)
Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody. (1979) (55)
Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States (2017) (55)
Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. (2015) (54)
Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm (2009) (54)
The effects of HIV protease inhibitors on carbohydrate and lipid metabolism (2004) (54)
Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome. (2003) (53)
Evidence for cAMP-independent inhibition of S-phase DNA synthesis by prostaglandins. (1983) (52)
Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells. (1991) (52)
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy. (1986) (52)
Tumor necrosis factor, cytokines, and the hyperlipidemia of infection (1991) (51)
Ceramide Stimulates ABCA12 Expression via Peroxisome Proliferator-activated Receptor δ in Human Keratinocytes* (2009) (51)
HIV, inflammation, and calcium in atherosclerosis. (2014) (51)
Permeability barrier disruption alters the localization and expression of TNFα/protein in the epidermis (1994) (51)
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. (2011) (50)
Regulation of Glycosphingolipid Metabolism in Liver during the Acute Phase Response* (1999) (50)
Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis. (1998) (50)
Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-alpha. (1991) (49)
Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1993) (49)
Urinary Markers of Kidney Injury and Kidney Function Decline in HIV-Infected Women (2012) (48)
Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response Published, JLR Papers in Press, July 17, 2006. (2006) (48)
Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. (2008) (47)
Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. (1999) (46)
Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1) Published, JLR Papers in Press, March 18, 2006. (2006) (45)
In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. (1992) (45)
A genome-wide association study of carotid atherosclerosis in HIV-infected men (2010) (45)
HIV protease inhibitors increase adiponectin levels in HIV-negative men. (2004) (45)
Lipids: a key player in the battle between the host and microorganisms1 (2012) (45)
Incidence and Risk Factors for Acute Kidney Injury in HIV Infection (2012) (44)
Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters. (1997) (44)
Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome. (1997) (43)
Urinary biomarkers of kidney injury are associated with all‐cause mortality in the Women's Interagency HIV Study (WIHS) (2014) (43)
Fatty acid synthesis in obese insulin resistant diabetic mice. (1994) (42)
Reduced Kidney Function and Preclinical Atherosclerosis in HIV-Infected Individuals: The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) (2011) (42)
The Effect of Endocrine Disorders on Lipids and Lipoproteins (2000) (42)
Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1999) (41)
HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Paradox” (2016) (41)
The effect of diet on tumor necrosis factor stimulation of hepatic lipogenesis. (1990) (41)
A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans (2014) (41)
Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons. (2005) (41)
Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism. (1991) (41)
Wasting in the acquired immunodeficiency syndrome. (1992) (41)
Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin. (2001) (40)
Pathophysiology and treatment of the AIDS wasting syndrome. (1995) (40)
Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis. (2011) (39)
Indinavir increases glucose production in healthy HIV-negative men (2004) (38)
Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. (2010) (38)
Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. (2006) (37)
What causes wasting in AIDS? (1995) (37)
Cloning of Murine Translation Initiation Factor 6 and Functional Analysis of the Homologous Sequence YPR016c in Saccharomyces cerevisiae * (1999) (36)
Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue (2012) (36)
Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts. (1980) (35)
Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels (2015) (35)
Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. (1996) (34)
Characterization of adrenocorticotropin receptors that appear when 3T3-L1 cells differentiate into adipocytes. (1985) (33)
HDL and innate immunity: a tale of two apolipoproteins11 See referenced articles, J. Lipid Res. 2008, 49: 1640–1645 and 1782–1793. (2008) (33)
Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection (2018) (33)
Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats. (1994) (32)
Mechanism of action of peptide hormones and catecholamines (1985) (32)
Suppression of estrogen-related receptor alpha and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response. (2005) (32)
Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality (2022) (31)
The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. (2004) (30)
Upregulation of uncoupling protein 2 mRNA in genetic obesity: lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-alpha. (2000) (30)
Pathophysiology of the AIDS wasting syndrome. (1992) (30)
The fatty liver in AIDS. (2002) (29)
Insulin resistance in HIV infection: drugs, host responses, or restoration to health? (2008) (29)
Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. (1995) (29)
Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects. (2008) (29)
The interaction of 125I-insulin with cultured 3T3-L1 adipocytes: quantitative analysis by the hypothetical grain method. (1983) (28)
Parathyroid hormone-related protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase response. (1997) (28)
Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness (2010) (27)
Inflammation inhibits GPR81 expression in adipose tissue (2011) (27)
Hypokalemia and diabetes mellitus. (1983) (27)
HIV infection is associated with decreased thrombin generation. (2012) (27)
Expression and regulation of mRNA for putative fatty acid transport related proteins and fatty acyl CoA synthase in murine epidermis and cultured human keratinocytes. (1998) (27)
The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy (2009) (26)
Tissue-Specific Regulation of Insulin Receptor mRNA Levels in Rats With STZ-Induced Diabetes Mellitus (1992) (26)
Endotoxin induces parathyroid hormone-related protein gene expression in splenic stromal and smooth muscle cells, not in splenic lymphocytes. (1995) (25)
Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1993) (25)
Parotid secretory protein is an HDL-associated protein with anticandidal activity. (2005) (25)
Identification and characterization of the ligand-binding domain of insulin receptor by use of an anti-peptide antiserum against amino acid sequence 241-251 of the alpha subunit. (1991) (25)
The Effects of Cytokines on Intermediary Metabolism (1994) (25)
TNF-α is not the cause of fatty liver disease in obese diabetic mice (2001) (24)
Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients (2017) (24)
Localization of tumor necrosis factor–stimulated DNA synthesis in the liver (1991) (24)
Neutral lipid storage disease with ichthyosis: Lipid content and metabolism of fibroblasts (1988) (23)
Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men (2011) (23)
Antibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance. (1984) (23)
LIF and CNTF, which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats. (1996) (23)
Endotoxin in the gut and chylomicrons: translocation or transportation?11 See referenced article, J. Lipid Res. 2008, 50: 90–97. (2009) (23)
The effects of HIV protease inhibitors on carbohydrate and lipid metabolism (2005) (22)
Does HIV Infection Promote Early Kidney Injury in Women? (2014) (22)
Differential sensitivity of two functions of the insulin receptor to the associated proteolysis: kinase action and hormone binding. (1986) (22)
Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. (2007) (21)
Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis (2010) (21)
TNF-alpha is not the cause of fatty liver disease in obese diabetic mice. (2001) (21)
Fat Redistribution in Indinavir‐Treated Patients With HIV Infection: A Review of Postmarketing Cases (2000) (21)
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals. (2013) (21)
Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score. (2016) (21)
Increased lipopolysaccharide‐induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits (1995) (20)
Lipoproteins: Are they important components of host defense? (1997) (20)
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus (2018) (20)
Urea treatment allows dithiothreitol to release the binding subunit of the insulin receptor from the cell membrane: implications for the structural organization of the insulin receptor. (1985) (20)
Ceramides stimulate caspase‐14 expression in human keratinocytes (2013) (20)
Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation. (2018) (19)
Leptin and the immunosuppression of malnutrition. (2002) (19)
Obesity and Dyslipidemia (2015) (19)
Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans (2013) (19)
Cytokine regulation of parathyroid hormone-related protein messenger ribonucleic acid levels in mouse spleen: paradoxical effects of interferon-gamma and interleukin-4. (1994) (19)
Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection (2017) (19)
β-Nerve Growth Factor as a Mediator of the Acute Phase Responsein Vivo☆ (1996) (18)
Small intestinal fatty acid synthesis is increased in diabetic rats. (1990) (18)
Boosting Dose Ritonavir Does Not Alter Peripheral Insulin Sensitivity in Healthy HIV-Seronegative Volunteers (2010) (18)
Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS) (2019) (18)
HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection (2014) (18)
Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease (2011) (18)
Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine. (1994) (17)
Angiopoietin like protein 4 expression is decreased in activated macrophages. (2012) (17)
Teriparatide treatment of osteoporosis in an HIV-infected man: a case report and literature review. (2015) (16)
Psoriasis: it's more than just the skin1 (2012) (16)
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum. (2006) (16)
Long-Term Subcutaneous Tissue Changes Among Antiretroviral-Naive Persons Initiating Stavudine, Zidovudine, or Abacavir With Lamivudine (2008) (16)
Keratinocyte growth factor increases fatty acid mobilization and hepatic triglyceride secretion in rats. (1995) (16)
Nicotinamide and other inhibitors of ADP-ribosylation block deoxyglucose uptake in cultured cells. (1984) (15)
Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. (2000) (15)
Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production. (2014) (15)
Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice. (2002) (15)
Prevalence and factors associated with dry skin in HIV infection: the FRAM study (2007) (14)
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults (2016) (14)
Taste preferences of infants for sweetened or unsweetened foods. (1980) (14)
Autoantibodies to insulin receptors in man: immunological determinants and mechanism of action. (1982) (13)
Effect of inter-reader variability on outcomes in studies using carotid intima media thickness quantified by carotid ultrasonography (2010) (13)
Hyperinsulinemic response to oral glucose challenge in individuals with posttraumatic stress disorder (2014) (12)
Insulin-stimulated methylaminoisobutyric acid uptake in 3T3-L1 fibroblasts and fat cells. (1983) (12)
Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women (2017) (12)
Structure-Activity Relationships of Adrenergic Compounds on the Adenylate Cyclase of Frog Erythrocytes (1974) (11)
Endotoxin , TNF , and ILI decrease cholesterol 7 a-hydroxylase mRNA levels and activity (2002) (11)
Pharmacokinetics, biological effects, and distribution of (1→3)-β-D-glucan in blood and organs in rabbits (1997) (11)
Serum albumin and kidney function decline in HIV-infected women. (2014) (11)
Glucocorticoid-induced insulin resistance in vitro: inhibition of insulin-stimulated methylaminoisobutyric acid uptake. (1986) (10)
CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation (2017) (10)
Downregulation of liver X receptor-α in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines Published, JLR Papers in Press, August 16, 2005. DOI 10.1194/jlr.M500134-JLR200 (2005) (10)
Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes (2011) (10)
The Pathogenesis of Atherosclerosis Effects of infection and inflammation on lipid and lipoprotein metabolism : mechanisms and consequences to the host 1 (2004) (9)
Relation of coronary artery plaque location to extent of coronary artery disease studied by computed tomographic angiography. (2010) (9)
Identification of the intact insulin receptor using a sequence-specific antibody directed against the C-terminus of the beta-subunit. (1987) (9)
The wasting syndrome in AIDS: mechanisms and implications. (1998) (9)
Insulin resistance: pathophysiology, diagnosis, and therapeutic implications. (1984) (8)
Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women (2019) (8)
Receptors for insulin and insulin-like growth factors in disease. (1980) (8)
Ketonuria in Hospitalized Patients With Non-Insului-Dependent Diabetes Mellitus (1986) (8)
Racial Differences in Changes of Metabolic Parameters and Body Composition in Antiretroviral Therapy-Naive Persons Initiating Antiretroviral Therapy (2009) (8)
Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors. (2006) (8)
The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers (2010) (8)
Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. (1994) (8)
HIV protease inhibitors and glucose metabolism. (2002) (7)
Association of Increased Upper Trunk and Decreased Leg Fat With 2-h Glucose in Control and HIV-Infected Persons (2011) (7)
Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study (2019) (7)
Regulation of lipid metabolism bycytokines during host defense (1996) (7)
Autoantibodies Against the Insulin Receptor: Dissociation of the Acute Effects of the Antibodies from the Desensitization Seen with Prolonged Exposure (1985) (7)
Beta-nerve growth factor as a mediator of the acute phase response in vivo. (1996) (7)
Approach to the Patient with Dyslipidemia (2015) (7)
Surface interactions and intracellular localization of cationic ferritin: similarity to 125I-insulin in 3T3-L1 adipocytes. (1983) (7)
The Acute Effects of HIV Protease Inhibitors on Insulin Suppression of Glucose Production in Healthy HIV-Negative Men (2009) (7)
Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy. (2004) (7)
Intermuscular Adipose Tissue and Metabolic Associations in HIV Infection (2011) (7)
Role of Glucose and Lipids in the Cardiovascular Disease of Patients with Diabetes (2015) (7)
Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages Published, JLR Papers in Press, June 1, 2003. DOI 10.1194/jlr.M300100-JLR200 (2003) (6)
Effect of Tumor Necrosis Factor ( TNF ) on Lipid Metabolism in the Diabetic Rat (2013) (6)
Understanding the complications of antiretroviral drugs. (2008) (6)
Molecular pharmacology of plant lectins: studies on ricin and concanavalin A (NSC-143504). (1974) (6)
Autoantibodies to the insulin receptor and insulin-resistant diabetes. (1982) (6)
Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV. (2017) (6)
Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. (1998) (5)
HIV and Hepatitis C – Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 ( PCSK 9 ) : An Apparent “ PCSK 9 – Lipid Paradox ” (2016) (5)
Regulation of hepatic lipid metabolism by cytokines that induce the acute phase response. (1992) (5)
Suppression of estrogen-related receptor α and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500217-JLR200 (2005) (5)
Increased hepatic insulin proreceptor-to-receptor ratio in diabetes: a possible processing defect. (1991) (5)
Utility of Advanced Lipoprotein Testing in Clinical Practice (2016) (5)
Calories lost — another mediator of cancer cachexia? (1996) (5)
Diabetes and Dyslipidemia (2015) (4)
Contributions of HIV, HCV, and traditional vascular risk factors to peripheral artery disease in women. (2019) (4)
Fat Distribution in Men With HIV Infection From the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) (2011) (4)
Leptinemia is Associated With Peripheral Artery Disease. (2019) (4)
Cloning and characterization of a cDNA encoding human cardiolipin synthase ( hCLS 1 ) (2006) (4)
Association of Statin Use with Kidney Damage and Function Among HIV-infected Men (2019) (3)
Deep sequencing of RYR3 gene identifies rare and common variants associated with increased carotid intima-media thickness (cIMT) in HIV-infected individuals (2014) (3)
The association of adiposity with kidney function decline among HIV‐infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study (2015) (3)
Association of glucocorticoid receptor haplotypes with body composition and metabolic parameters in HIV-infected patients from the FRAM study (2014) (3)
Modulation of the insulin receptor by insulin receptor autoantibodies. (1980) (3)
Insulin resistance is independently associated with VAT and upper trunk SAT in controls and HIV infection (2006) (3)
Peptide-Based Radioimmunoassay for Insulin Receptor: Detection of Insulin-Stimulated Downregulation in IM-9 Lymphocytes (1989) (2)
Endocrine complications of HIV infection (2012) (2)
Nutrition in HIV infection (1994) (2)
Growth Hormone Research and Therapy (1997) (2)
Kidney tubule health scores and their associations with incident CKD in women living with HIV (2021) (2)
Fish oil for treatment of hypertriglyceridemia in HIV infection: fish or foul? (2005) (2)
Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV (2021) (2)
Use of cystatin C to inform metformin eligibility among adult veterans with diabetes (2016) (2)
Which Cytokines Mediate the Metabolic Effects of Endotoxin (Lipopolysaccharide) (1993) (1)
Effects of Recombinant Human Growth Hormone on Body Composition and Metabolism in HIV-Associated Wasting (1995) (1)
Manual Die Cutting and Creasing Machine Carton Box Making (2011) (1)
Precision Injection Mould Nitrided SKD61 JIS DIN Ejector Pin (2011) (1)
Status asthmaticus, mechanical ventilation, and pneumothorax. (1978) (1)
Diabetes in HIV‐infected persons in Cameroon? (2016) (1)
CHAPTER 27 – Endocrine Complications of HIV Infection (2008) (1)
Fashion Design Women Flats Slip on Plus Size Ladies Shoes (2011) (1)
In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. (1998) (1)
Abstract P200: The Heart and Cannabis Cohort (THC Cohort): Associations Between Cannabis Use and Cardiovascular Health at Cohort Inception (2020) (0)
Table 3, Disorders that Increase Triglyceride Levels (2015) (0)
4P-1018 Parotid secretory protein is associated with HDL and expressed in respiratory epithelium, keratinocytes, sebaceous glands, and gonads (2003) (0)
In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. (1999) (0)
Table 7, Effect of Lipid Lowering Drugs (2015) (0)
Table 4, Effect of Lipid Lowering Drugs (2015) (0)
Biobase Stainless Steel Pass Box with Cheap Price (2011) (0)
HIV ELITE CONTROLLERS HAVE LOWER ASYMMETRIC DIMETHYLARGININE AND IMPROVED ENDOTHELIAL FUNCTION AS COMPARED TO INDIVIDUALS WITH TREATED AND SUPPRESSED HIV (2013) (0)
Table 2, Fibrate Trials - Diabetic Subgroup (2015) (0)
The Interaction of '251-Insulin with Cultured 3T3-L1 Adipocytes: (1983) (0)
Nadir CD4+ and Elevated ADMA are Associated with Endothelial Dysfunction in HIV-Infected Individuals (2000) (0)
Chylomicrons EnhanceEndotoxin Excretion inBile (1993) (0)
Figure 9, [Cholesterol Efflux from Macrophages (modified from J. Clinical Investigation 116: 3090, 2006)]. (2015) (0)
Amitriptyline and Fluphenazine for Painful Diabetic Neuropathy-Reply (1986) (0)
Bone marrow adipose tissue composition and glycemic improvements after gastric bypass surgery (2022) (0)
Figure 3, LDL Receptor Pathway (figure modified from Annual Review of Biochemistry 46: 897, 1977) (2015) (0)
Figure 4, SREBP Pathway (figure modified from Journal of Lipid Research 50: Supp S15, 2009) (2015) (0)
P-114: Role of intestinal lipogenesis in the hyperlipidemia of non-insulin dependent diabetes mellitus (2009) (0)
Figure 1, Pathogenesis of Hypertriglyceridemia (2015) (0)
[Table, Table 1. CARDIA Study]. (2016) (0)
Table 1, Patients at Very High Risk of High Risk for Cardiovascular Disease (2015) (0)
Table 5, [Dietary Constituents]. (2015) (0)
Car Fuel Injector Nozzle 25345994A Adapt for Chevy Corsa Meriva Montana Tornado (2011) (0)
Tumor Necrosis Factor Alpha Stimulates Hepatic Lipid Synthesis in vivo (1988) (0)
Figure 1, [PATHOPHYSIOLOGY OF THE DYSLIPIDEMIA OF OBESITY]. (2015) (0)
Table 9, Elevations in Triglycerides and Cholesterol (2015) (0)
The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use (2022) (0)
Changes in vertebral bonemarrow fat and bonemass after gastric bypass surgery : A pilot study ☆ , ☆ ☆ , ★ (2015) (0)
State of the art in wasting: an interview with Carl Grunfeld, PhD. Interview by Jeff Getty. (1995) (0)
Table 2, Beneficial Effects of Lipoproteins (2015) (0)
Table 1, Pro-Atherogenic Changes During Inflammation (2015) (0)
Figure 4, Effect of Inflammation on Reverse Cholesterol Transport (from reference 61) (2015) (0)
Table 4, Drugs that Increase Triglyceride Levels (2015) (0)
Otitis media. (1978) (0)
Table 6, Drugs that Decrease HDL Levels (2015) (0)
Intermuscular a dipose Tissue and Metabolic a ssociations in HIV Infection (2011) (0)
Table 1, Statin Trials- Diabetic Subgroups (2015) (0)
PCSK9 IS ELEVATED IN PATIENTS WITH HIV AND HEPATITIS C (2015) (0)
Figure 6, Intestinal Cell and Sterol Metabolism (2015) (0)
' s response to reviews Title : Uromodulin Concentrations are not Associated with Incident CKD Among Persons with Coronary Artery Disease (2010) (0)
Body Composition Changes over the Menopausal Transition in Women With and Without HIV. (2023) (0)
Figure 2, Classes of Lipoproteins (figure modified from Advances Protein Chemistry 45:303, 1994) (2015) (0)
Table 4, NLA Treatment Goals (2015) (0)
Table 5, Disorders that Decrease HDL Levels (2015) (0)
Table 3, Recommendations for statin treatment in people with diabetes (2015) (0)
Disease Risk Factors Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular (2008) (0)
Table 2, Drugs that Increase LDL levels (2015) (0)
Table 2, Classification of HDL (2015) (0)
Weight loss and the role of secondary infection in AIDS wasting. (1999) (0)
Summary Increase Quality of Care for Patients Living With HIV/AIDS: Executive State of the Science Conference: Initiative to Decrease Cardiovascular Risk and (2008) (0)
Figure 2, Changes in HDL Protein Composition During Inflammation (2015) (0)
Psa Nitrogen Generator with High Purity Automatic Running (2011) (0)
Table 1, Lipoprotein Classes (2015) (0)
Table 1, Disorders that Increase LDL cholesterol (2015) (0)
Table 8, Marked Elevations in Triglycerides (Chylomicrons) (2015) (0)
During Activation of Murine Macrophages by Toll-Like Receptor Agonists Binding Protein Expression and Lipid Accumulation Are Increased − Adipocyte Fatty Acid (2005) (0)
Abstract 11142: Association of Age, Race, and HIV Disease Severity with Incident Atrial Fibrillation in HIV-Infected Persons (2012) (0)
Title Uromodulin concentrations are not associated with incident CKD among persons with Coronary artery disease Permalink (2011) (0)
Table 7, Elevation in LDL Cholesterol (Familial Hypercholesterolemia) (2015) (0)
Figure 2, [Combined Hyperlipidemia. Increased LDL and TG]. (2015) (0)
LOWER CD4 NADIR AND HIGH HIV VIRAL LOAD ARE ASSOCIATED WITH ELEVATED LEVELS OF ADMA IN HIV-INFECTED PATIENTS (2012) (0)
134 SONOGRAPHY OF THE SOLE OF THE FOOT: Normal Criteria and Findings in Diabetes (1985) (0)
Original Investigation Serum Albumin and Kidney Function Decline in HIV-Infected Women (2014) (0)
[Table, Table 2. Risk of Cardiovascular Disease in Statin Treated Patients (Hazard Ratios)]. (2016) (0)
Table 3, Apolipoproteins (2015) (0)
Figure 1, Lipoprotein Structure (figure modified from Biochemisty 39: 9763, 2000) (2015) (0)
Repression of lipin‐1 in mouse adipose tissue and 3T3‐L1 adipocytes by LPS and proinflammatory cytokines (2007) (0)
Chylomicrons enhance endotoxin excretion in (1993) (0)
Table 5, Comparative Efficacy of Available Statins (2015) (0)
Therapy for Treatment of the Wasting Syndrome in Cancer and AIDS: What Can We Do and What Should We Do?* (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Carl Grunfeld?

Carl Grunfeld is affiliated with the following schools:

Carl Grunfeld's Academic­Influence.com Rankings

Carl Grunfeld's Degrees

Why Is Carl Grunfeld Influential?

Carl Grunfeld's Published Works

Published Works

What Schools Are Affiliated With Carl Grunfeld?

Carl Grunfeld's AcademicInfluence.com Rankings